Ajanta Pharma Limited
AJANTPHARM
Ранг среди акций
#3733
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Цена акции
$35.98
Рыночная капитализация
$4.50B
Изменение (1 день)
-1.18%
Изменение (1 год)
29.38%
Страна
IN
Торговля Ajanta Pharma Limited (AJANTPHARM)
Категория
Healthcare
Прибыль Ajanta Pharma Limited (AJANTPHARM)
Прибыль на Jun 2026 TTM: $164.80M
Согласно последним финансовым отчетам Ajanta Pharma Limited, текущая прибыль компании составляет $164.80M. В 2024 году компания получила прибыль $133.59M, больше, чем прибыли за 2023, которая составила $90.68M. Отображаемая прибыль на этой странице — это прибыль до уплаты процентов и налогов, или просто EBIT.
История прибыли компании Ajanta Pharma Limited с 2005 по 2026
Прибыль в конце каждого года
| Год | Прибыль | Изменить |
|---|---|---|
| 2026 (TTM) | $164.80M | 18.53% |
| 2025 | $139.04M | 4.08% |
| 2024 | $133.59M | 47.31% |
| 2023 | $90.68M | -24.31% |
| 2022 | $119.81M | -2.57% |
| 2021 | $122.97M | 39.52% |
| 2020 | $88.14M | 19.01% |
| 2019 | $74.06M | -22.54% |
| 2018 | $95.62M | -4.34% |
| 2017 | $99.95M | 20.97% |
| 2016 | $82.63M | 13.06% |
| 2015 | $73.08M | 32.80% |
| 2014 | $55.03M | 69.13% |
| 2013 | $32.54M | 81.39% |
| 2012 | $17.94M | 41.32% |
| 2011 | $12.69M | 47.07% |
| 2010 | $8.63M | 46.96% |
| 2009 | $5.87M | -18.63% |
| 2008 | $7.22M | 61.49% |
| 2007 | $4.47M | 39.66% |
| 2006 | $3.20M | 48.67% |
| 2005 | $2.15M | 0.00% |
Прибыль схожих компаний или конкурентов
| Компания | Прибыль | Разница в прибыли | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 970.72% |
IN
|
